Furusawa K, Sugiyama H, Tokuhiro A, Takahashi M, Nakamura T, Tajima F
Department of Rehabilitation Medicine, Kibikogen Rehabilitation Center for Employment Injuries, Okayama, Japan.
Spinal Cord. 2009 Feb;47(2):144-8. doi: 10.1038/sc.2008.86. Epub 2008 Jul 15.
Prospective double-blind study.
Manual emptying of rectal contents is necessary for patients with spinal cord injury to prevent bowel obstruction; however, this maneuver induces a rise in blood pressure (BP) and autonomic dysreflexia (AD). The purpose of this prospective double-blind study was to investigate whether topical anorectal anesthesia attenuates the BP rise and AD during bowel manipulation in patients with cervical spinal cord injury (CSCI).
Kibikogen Rehabilitation Center for Employment Injuries.
The study subjects were 25 consecutive clinically stable patients with CSCI. Each subject received a complete bowel program involving manual removal of stool in lateral recumbency, after topical application of lidocaine or placebo jelly to the anorectal area. Systolic and diastolic BP, heart rate and symptoms of AD were recorded before, during and after bowel manipulation.
Systolic BP was significantly lower during the lidocaine arm of the study compared with placebo at insertion of rectal medication, digital stimulation, beginning of stool flow, manual removal of stool, end of stool flow and at 5-min after emptying. The mean maximal increase in systolic BP during lidocaine treatment (33.2+/-14.6 mm Hg) was less than during placebo (50.2+/-19.5 mm Hg, P<0.001).
On the basis of our findings, we recommend induction of lidocaine jelly immediately before rectal manipulation in patients with CSCI to minimize the incidence and severity of AD.
前瞻性双盲研究。
脊髓损伤患者需要手动排空直肠内容物以预防肠梗阻;然而,此操作会导致血压(BP)升高和自主神经反射异常(AD)。这项前瞻性双盲研究的目的是调查局部肛门直肠麻醉是否能减轻颈脊髓损伤(CSCI)患者肠道操作期间的血压升高和AD。
Kibikogen工伤康复中心。
研究对象为25例连续的临床病情稳定的CSCI患者。每位受试者在肛门直肠区域局部应用利多卡因或安慰剂凝胶后,接受包括侧卧位手动排便的完整肠道程序。在肠道操作前、操作期间和操作后记录收缩压和舒张压、心率以及AD症状。
在直肠给药插入、数字刺激、开始排便、手动排便、排便结束以及排空后5分钟时,与安慰剂相比,研究中利多卡因组的收缩压显著更低。利多卡因治疗期间收缩压的平均最大升高幅度(33.2±14.6 mmHg)小于安慰剂组(50.2±19.5 mmHg,P<0.001)。
基于我们的研究结果,我们建议CSCI患者在直肠操作前立即使用利多卡因凝胶,以将AD的发生率和严重程度降至最低。